RxDoctor Payments Data

Ernest Howard, MD

Physical Medicine & Rehabilitation · Atlanta, GANPI 1568449478

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 99.2% of the total across 149 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 16 manufacturers reported payments, led by Collegium Pharmaceutical, Inc. at 44.6% of the total.

$2,685in general payments, 2019–2025

Across 149 payments — averaging $18.02 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Collegium Pharmaceutical, Inc.$1K
  • Salix Pharmaceuticals, A Division Of Bausch Health US, LLC$565
  • Redhill Biopharma Inc.$195
  • Pfizer$191
  • Hikma Pharmaceuticals USA$149
  • Biodelivery Sciences International, Inc.$83
  • plus $305 from 10 others

What the payments were for

  • Food & beverage$2,66499%
  • Education$211%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$2,685 in reported general payments places this provider in the 80th percentile of 214 physical medicine & rehabilitation providers in Georgia.

See all physical medicine & rehabilitation providers in Georgia

Medicare billing

Part B allowed, 2024
$54,139
Medicare patients
121
Services billed
581

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen3,341$97,472
Xtampza ErOxycodone Myristate141$71,576
BelsomraSuvorexant109$47,840
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen1,342$33,967
OxycontinOxycodone Hcl34$27,066
Buprenorphine87$21,438
BotoxOnabotulinumtoxina15$19,098
Oxycodone Hcl854$17,263
Morphine Sulfate ErMorphine Sulfate650$13,863
Pregabalin685$12,626
BelbucaBuprenorphine Hcl16$11,652
LyricaPregabalin13$11,093
MovantikNaloxegol Oxalate19$9,025
Diclofenac Sodium92$7,403
Fentanyl72$6,588

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Collegium Pharmaceutical, Inc.Xtampza Er, Belbuca$1,196$83,228157 claims
MerckBelsomra$60$47,840109 claims
Hikma Pharmaceuticals USABuprenorphine, Morphine Sulfate$149$23,694169 claims
PfizerLyrica$191$11,09313 claims
Redhill Biopharma Inc.Movantik$195$9,02519 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 80th percentile of 214 physical medicine & rehabilitation providers in Georgia.

Other physical medicine & rehabilitation in Atlanta

See the full list for Georgia

Where these figures come from

Is this you, or does something look wrong? →